Immuno-Multi-Therapy and Prophylaxis Efficacy against COVID-19
Journal Title: Journal of Clinical Immunology & Microbiology - Year 2021, Vol 2, Issue 1
Abstract
In the context of the current COVID-19 pandemic, strategies for finding effective therapies advocate the so-called "therapeutic repositioning" approach, i.e., the use of existing molecules on the pharmaceutical market, whose toxicity and therapeutic efficacy are known. The immunotherapy proposed in this study consisted to use four well-known components of validated therapeutic drugs, namely: interferon type 1 (IFNα), interferon type 2 (IFNγ), chloroquine (Chloroquine phosphate) and antioxidants (Vitamins A, C, E, trace elements and lycopene). Such non pathogen specific treatment was curative and preventive (i.e., prophylaxis), and expected to enhance the patient's innate response. A selected cohort consisted of 122 patients tested positive by RT-PCR (SARS-CoV-2 infection). Among them, 89 patients were asymptomatic and 43 symptomatic (COVID-19). Due to the compassionate nature of this therapeutic approach, age, and gender were randomized. Four types of treatment were selected using a multi-therapy approach applied for a duration of five days. Among the medical team in charge of the protocol ten (10) were subjected for prophylactic purposes to a three-day tritherapy treatment. A total of 132 participants received a multi-therapy treatment as curative treatment (122 patients) and as prevention (10 health workers). All participants were tested for RT-PCR before treatment, all patients tested positive while the health workers tested negative. After two weeks all participants tested negative by RT-PCR. Clinical follow-up showed a total and rapid recovery at the early stage of tri-immunotherapy while repeated RT-PCR testing for the participants with preventive treatment remained negative. Conclusion. Such multi-immunotherapy protocols against SARS-CoV-2 efficacy appear substantial for treatment and potentially efficient for health worker prevention. Due to our limited subject and the compassionate context, all multi-immunotherapy protocols would require a control study to evaluate their efficacy.
Authors and Affiliations
Lungu P Anzwal*, Kalumba A Kambote, Tshinawej P Mukiny, Sadiki P Wabula, Moba C Iselenge, Bangutulua V Mbezi, Mokalu S Maope, Jean-Paul J Gonzalez, Balaka M Ekwalanga
Keywords
Related Articles
- EP ID EP699094
- DOI http://dx.doi.org/10.46889/JCIM.2021.2109
- Views 74
- Downloads 0
The Pandemic, the Immunizations and the Mutating Viruses
The world famous virologist Luc Montagnier, who received the Nobel Prize in Medicine in 2008 for deciphering the DNA of the HIV causing AID’s disease, said in an interview in the French documentary “Hold-up” that one o...
The Spheroid Smarting- Glomus Tumour
Glomus tumour is benign, perivascular hamartoma arising from glomus apparatus or a mesenchymal neoplasm essentially comprised of modified smooth muscle cells, also termed as glomangioma, glomangiomyoma or glomangiomato...
Immuno-epidemiology and Transmission Characteristics of SARS-CoV-2: A Perspective Investigation
Coronaviruses propagate efficiently within the heterogeneous population of humans to disperse infections. For Severe Acute Respiratory Syndrome Coronavirus-2 the determination of the heterogeneity of individual infecti...
Immuno-Multi-Therapy and Prophylaxis Efficacy against COVID-19
In the context of the current COVID-19 pandemic, strategies for finding effective therapies advocate the so-called "therapeutic repositioning" approach, i.e., the use of existing molecules on the pharmaceutical market,...
Revealing the Wave (Quantum) Nature of Acupuncture and Acupuncture Analgesia
The acupuncture points are electrically conducting ellipses aligned with their long axes along a line called acupuncture meridian and they are imbedded in the semi-conducting tissue of the body. Since the media is electr...